Alberto Mantovani
 |
| Alberto Mantovani | |
|---|---|
 | |
| Nascimento | 29 de outubro de 1948 (76 anos) Milão |
| Nacionalidade | Italiano |
| Cidadania | Itália |
| Alma mater | |
| Ocupação | médico, imunologista, oncologista |
| Distinções | Prêmio Robert Koch (2016), Prêmio Antonio Feltrinelli (2016) |
| Empregador(a) | Universidade de Milão, William Harvey Research Institute, Humanitas Research Hospital, Mario Negri Institute for Pharmacological Research, Mario Negri Institute for Pharmacological Research, Mario Negri Institute for Pharmacological Research, Institutos Nacionais da Saúde, Mario Negri Institute for Pharmacological Research |
| Campo(s) | oncologia, imunologia |
Alberto Mantovani (Milão, 29 de outubro de 1948) é um médico oncologista e imunologista italiano.[1]
Recebeu o Prêmio Robert Koch [2] e o Prêmio Antonio Feltrinelli de 2016.
Publicações
[editar | editar código-fonte]- com Charles A. Dinarello, Petro Ghezzi: Pharmacology of Cytokines, Oxford University Press 2000
- Editor: Chemokines, Basel: Karger 1999
- Cancer: Inflaming metastasis, Nature, Band 457, 2009, S. 36-37
- com P. Allavena, A. Sica, F. Balkwill: Cancer-Related Inflammation, Nature, Band 454, 2008, S. 436-444
- com F. Balkwill: Inflammation and cancer: back to Virchow ?, Lancet, Band 357, 2001, S. 539-545
- com F. Colotta, F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. G. Giri, S. K. Dower, J. E. Sims: Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4, Science, Band 261, 1993, S. 472-475
- com V. Rossi, F. Breviario, P. Ghezzi, E. Dejana: Prostacyclin synthesis induced in vascular cells by interleukin-1, Science. Band 229, 1985, S. 174-176
- com B. Bottazzi, N. Polentarutti, R. Acero, A. Balsari, D. Boraschi, P. Ghezzi, M. Salmona: Regulation of the macrophage content of neoplasms by chemoattractants. Science, Band 220, 1983, S. 210-212
- com A. Sica: Macrophage plasticity and polarization: in vivo veritas, J Clin Invest. Band 122, 2012, S. 787-795
- com C. Garlanda, C. A. Dinarello: The IL-1 family: back to the future, Immunity, Band 39, 2013, S. 1003-1018
- com C. Garlanda u.a.: Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response, Nature, Band 420, 2002, S. 182-186
- com B. Bottazzi, A. Doni, C. Garlanda: An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm. Annual Review Immunol., Band 28, 2010, S. 157-183
- com S. K. Biswas: Macrophage plasticity and interaction with lymphocyte subsets: cancer as paradigm, Nature Immunol., Band 11, 2010, S. 889-896
- com F. Re, M. Muzio, M. De Rossi, N. Poletarutti, J. G. Giri, F. Colotta: The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor, J. Exp. Med., Band 179, 1994, S. 739-743
- com E. Bonavita u.a.: PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer, Cell, Band 160, 2015, S. 700-714
